Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study
Year: 2013
Type: article
Source: Lung Cancer
Institutions: Guangdong General Hospital, Guangdong Academy of Medical Sciences, Kindai University, Chinese University of Hong Kong, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University, National Taiwan University, National Taiwan University Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, AstraZeneca (United Kingdom)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2022575295
